MedPath

Fetal Anomalies Scan at the Time of Nuchal Translucency Study

Conditions
Fetal Anomalies
Registration Number
NCT00943189
Lead Sponsor
Sheba Medical Center
Brief Summary

Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.

Detailed Description

Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal and transabdominal techniques. The patients will receive only the NT information. Only in cases of detection of severe fetal anomalies the patient will get the information of the examination and counseling according to the findings. All patients will be asked to provide information of the 15 weeks early comprehensive ultrasound examination. The NT examination will be compared to the 15 weeks ultrasound. All patients will be asked to give information after delivery of the baby's health condition.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • pregnant women at 12-14 weeks
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath